After finishing at $3.29 in the prior trading day, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) closed at $3.17, down -3.65%. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 627567 shares were traded. MREO stock price reached its highest trading level at $3.2700 during the session, while it also had its lowest trading level at $3.1400.
Ratios:
Our goal is to gain a better understanding of MREO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.11. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.08.
On August 12, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $4.
On May 05, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $10.BTIG Research initiated its Buy rating on May 05, 2021, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 446.02M and an Enterprise Value of 394.55M. For the stock, the TTM Price-to-Sale (P/S) ratio is 50.51 while its Price-to-Book (P/B) ratio in mrq is 5.54. Its current Enterprise Value per Revenue stands at 39.45 whereas that against EBITDA is -15.14.
Stock Price History:
Over the past 52 weeks, MREO has reached a high of $4.36, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 3.5516, while the 200-Day Moving Average is calculated to be 2.1967.
Shares Statistics:
The stock has traded on average 1.78M shares per day over the past 3-months and 974.03k shares per day over the last 10 days, according to various share statistics. A total of 140.06M shares are outstanding, with a floating share count of 140.06M. Insiders hold about 0.00% of the company’s shares, while institutions hold 61.40% stake in the company. Shares short for MREO as of Mar 15, 2024 were 2.19M with a Short Ratio of 1.23, compared to 2.78M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.56% and a Short% of Float of 2.17%.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
